Wednesday, January 01, 2014 2:39:30 PM
Dear Frank,
On July 30, 2013 you posted this letter to shareholders on PharmaJanes.com
Since this letter many months have passed and shareholders who have invested based on these statements have seen their investments decrease significantly. I believe your intentions in this letter were honest. The inaccurate expectations in this letter followed by your silence and SIGNIFICANT SHARE DILUTION, thus-far have compromised your professional reputation.
Previously, on March 21, 2013, this press release was issued:
Your President Mario Barrera said, "Hopefully, this activity will gradually reduce itself as the Asher notes are converted, at higher conversion prices." That seems like an irresponsible prediction of future share price. The president of a public company says "hopefully"? Fortunately I didn't invest based on any of Mr. Barrera's statements.
That 120 million shares issued in March has turned into over a BILLION additional shares since March. Again, no communication as to the extent of the beating your shareholders should hopefully not expect to take.
If HE can issue statements saying "hopefully" they will decrease at higher prices, followed by YOUR letter saying you've "assembled a team of experts to ensure that the launch of the PharmaJanes/Simple Prepay model is fast paced," the expectation has been set that the business is moving forward in a fast-paced manner and that shareholder should expect a rise in share price.
Your "team of experts" have failed at being "fast-paced" and your stock is so diluted it barely resembles it's recent self.
Hopefully, Mr. Barrera will resign. He is a joke of president and his career outside of Robert Hipple's companies is clearly over.
Hopefully, the iEquity family of delays is a result of not enough staff to run all of the companies that they are starting-up, and not anything dishonest.
Hopefully, PharmaJanes launches in January 2014 to capitalize on the abundance of media that will invade the sector. Shareholders will need this viral new investor interest to overcome the dilution.
Hopefully, we find out why you removed the AEGY stock quote from the from page of PharmaJanes.com
My research which hopefully is correct, leads me to believe that the delays are a result of Henry Jan, Kevin Allyn, and Jeffrey Benz not wanting to further dilute the shells you are merging into by issuing shares to pay for new hires. A lean staff would likely cause some delays. This would be an honorable strategy but without transparency, the hard facts say you're inadvertently involved in a share selling collusion between Robert Hipple, Michael Gelmon, and Asher Enterprises.
Also, in the press release from last March he said, "Members of the Collectives managed by SK3 Group will soon be able to order their medical cannabis needs through PharmaJanes™."
How exactly do you define soon?
The world is watching, timing is everything. Launch it Frank.
Best wishes,
BK
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM